Protection against CCl4-induced injury in liver by adenovirally introduced thioredoxin gene

Biochemical and Biophysical Research Communications

Volumn 350, Issue 1, 2006, Pages 157-161

  Isoda, Katsuhiro ^a   Arita, Eri ^a   Kojima, Midori ^a   Ikkaku, Masahiro ^a   Tashiro, Fumi ^b   Yamato, Eiji ^b   Miyazaki, Jun Ichi ^b   Kawase, Masaya ^a   Kondoh, Masuo ^a   Yagi, Kiyohito ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Adenovirus vector; Gene therapy; Liver injury; Oxidative stress; Thioredoxin

Indexed keywords

ADENOVIRUS VECTOR; ALANINE AMINOTRANSFERASE; AMMONIA; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; EOSIN; HEMATOXYLIN; THIOREDOXIN; TXN PROTEIN, HUMAN;

ADENOVIRUS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMMONIA BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; GENE EXPRESSION; GENE INSERTION; GENE TARGETING; LIVER; LIVER INJURY; MALE; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; STATISTICAL SIGNIFICANCE; ANIMAL; BLOOD; CELL CULTURE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENETICS; HUMAN; INFLAMMATION; LIVER DISEASE; METABOLISM; PATHOLOGY;

ADENOVIRIDAE;

ADENOVIRIDAE; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CARBON TETRACHLORIDE; CELLS, CULTURED; GENE EXPRESSION; HUMANS; INFLAMMATION; LIVER; LIVER DISEASES; MALE; MICE; RATS; THIOREDOXIN;

EID: 33749065545     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.09.014     Document Type: Article

References (18)

1. Tsutsui T., Koide H., Fukahori H., Isoda K., Higashiyama S., Maeda I., Tashiro F., Yamato E., Miyazaki J., Yodoi J., Kawase M., and Yagi K. Adenoviral transfection of hepatocytes with the thioredoxin gene confers protection against apoptosis and necrosis. Biochem. Biophys. Res. Commun. 307 (2003) 765-770
2. Arner E.S., and Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267 (2000) 6102-6109
3. Takagi Y., Mitsui A., Nishiyama A., Nozaki K., Sono H., Gon Y., Hashimoto N., and Yodoi J. Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc. Natl. Acad. Sci. USA 96 (1999) 4131-4136
4. Hotta M., Tashiro F., Ikegami H., Niwa H., Ogihara T., Yodoi J., and Miyazaki J. Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. J. Exp. Med. 188 (1998) 1445-1451
5. Shioji K., Kishimoto C., Nakamura H., Masutani H., Yuan Z., Oka S., and Yodoi J. Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity. Circulation 106 (2002) 1403-1409
6. Nakamura H., Tamura S., Watanabe I., Iwasaki T., and Yodoi J. Enhanced resistancy of thioredoxin-transgenic mice against influenza virus-induced pneumonia. Immunol. Lett. 82 (2002) 165-170
7. Okuyama H., Nakamura H., Shimahara Y., Uyama N., Kwon Y.W., Kawada N., Yamaoka Y., and Yodoi J. Overexpression of thioredoxin prevents thioacetamide-induced hepatic fibrosis in mice. J. Hepatol. 42 (2005) 117-123
8. Seglen P.O. Preparation of isolated rat liver cells. Methods Cell Biol. 13 (1976) 29-83
9. Tashiro F., Niwa H., and Miyazaki J. Constructing adenoviral vectors by using the circular form of the adenoviral genome cloned in a cosmid and the Cre-loxP recombination system. Hum. Gene Ther. 10 (1999) 1845-1852
10. Niwa H., Yamamura K., and Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108 (1991) 193-199
11. Huizenga J.R., Tangerman A., and Gips C.H. Determination of ammonia in biological fluids. Ann. Clin. Biochem. 31 (1994) 529-543
12. Weber L.W., Boll M., and Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit. Rev. Toxicol. 33 (2003) 105-136
13. Alemany R., Suzuki K., and Curiel D.T. Blood clearance rates of adenovirus type 5 in mice. J. Gen. Virol. 81 (2000) 2605-2609
14. Shayakhmetov D.M., Li Z.Y., Ni S., and Lieber A. Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors. J. Virol. 78 (2004) 5368-5381
15. Andoh T., Chock P.B., and Chiueh C.C. The roles of thioredoxin in protection against oxidative stress-induced apoptosis in SH-SY5Y cells. J. Biol. Chem. 277 (2002) 9655-9660
16. Tanaka T., Hosoi F., Yamaguchi Iwai Y., Nakamura H., Masutani H., Ueda S., Nishiyama A., Takeda S., Wada H., Spyrou G., and Yodoi J. Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J. 21 (2002) 1695-1703
17. Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., Kawabata M., Miyazono K., and Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17 (1998) 2596-2606
18. Galun E., and Axelrod J.H. The role of cytokines in liver failure and regeneration: potential new molecular therapies. Biochim. Biophys. Acta 1592 (2002) 345-358